Press Releases

CD Genomics Unveils Cutting-Edge 5mC/5hmC Sequencing Service to Drive Epigenomics Research Forward

Nov 30, 2023, 09:12 AM by

CD Genomics, a prominent leader in the next generation sequencing arena, proudly announce the launch of a groundbreaking 5mC/5hmC sequencing service. This innovative service is poised to empower researchers by providing a deeper insight into epigenetic variations, unlocking the mysteries of epigenetics, and catalyzing pivotal advancements in the realm of life science research and precision medicine.

 

Epigenetics is a field of genetics that delves into the influence of chemical modifications within the genome on gene expression and the transmission of genetic information. Of significant note are the chemical modifications 5mC (5-methylcytosine) and 5hmC (5-hydroxymethylcytosine), which play pivotal roles in the regulation of gene expression and cellular differentiation. A comprehensive understanding of the distribution and dynamic changes in 5mC and 5hmC is of paramount importance when unraveling processes such as tumorigenesis, neurodevelopment, and stem cell differentiation.

 

The 5mC/5hmC sequencing service by CD Genomics is designed to be a highly dependable tool for precisely identifying the location and extent of these critical epigenetic markers. This service leverages state-of-the-art sequencing technologies, providing researchers with data of the highest resolution to accurately determine the distribution of 5mC and 5hmC. In turn, this empowers researchers to gain a deeper insight into the role of these markers in diverse cell types and biological processes.

 

Why opt for CD Genomics' 5mC/5hmC sequencing service?

High-Quality Data: CD Genomics employs cutting-edge sequencing technologies(hMeDIP-seq, oxBS-seq, WGBS, RRBS et al,.) to ensure high-resolution, high-coverage data for the reliable detection and analysis of 5mC and 5hmC distribution.

 

Expert Team: CD Genomics prides itself on housing a seasoned team of scientists equipped with a profound understanding of epigenetics, capable of providing professional analysis and interpretation.

 

Customized Solutions: CD Genomics offers tailored sequencing solutions designed to align with your research requirements, ensuring they support your specific research objectives.

 

Data Analysis and Interpretation: In addition to offering sequencing services, CD Genomics also provides comprehensive data analysis and interpretation services, enabling you to gain a deeper understanding of your experimental results.

 

The applications of 5mC/5hmC sequencing are incredibly diverse and span various domains, including:

Cancer Research: The understanding of 5mC and 5hmC distribution in cancer cells can illuminate the mechanisms underlying tumorigenesis, offering new avenues for the treatment of cancer.

 

Neuroscience: The exploration of the roles played by 5mC and 5hmC in neurodevelopment and neurodegenerative diseases holds the promise of revealing new therapeutic targets.

 

Stem Cell Research: Investigating the dynamic changes of 5mC and 5hmC during stem cell differentiation provides valuable insights into the mechanisms that dictate cell fate determination.

 

"CD Genomics has long been dedicated to providing cutting-edge biotechnology services that facilitate groundbreaking research in the realm of epigenetics. The 5mC/5hmC sequencing service we offer is poised to empower your research, providing the key to unlocking the enigmas of epigenetics. ollaborate with CD Genomics as we embark on a new chapter in epigenomics research, propelling us toward the future of science." stated the senior scientist of CD Genomics.

 

Contact

Address: Shirley, NY 11967, USA

Email: contact@cd-genomics.com